Akzo Nobel N.V.
AKZOF
$63.59
-$7.90-11.05%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.50B | 11.46B | 11.47B | 11.59B | 11.52B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.50B | 11.46B | 11.47B | 11.59B | 11.52B |
| Cost of Revenue | 6.92B | 6.89B | 6.86B | 6.89B | 6.82B |
| Gross Profit | 4.58B | 4.57B | 4.62B | 4.69B | 4.70B |
| SG&A Expenses | 3.36B | 3.35B | 3.35B | 3.35B | 3.31B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 319.02M | 5.35M | 6.54M | 6.57M | -17.10M |
| Total Operating Expenses | 10.92B | 10.56B | 10.53B | 10.56B | 10.40B |
| Operating Income | 579.65M | 896.63M | 942.82M | 1.02B | 1.12B |
| Income Before Tax | 370.03M | 753.81M | 813.29M | 909.01M | 915.40M |
| Income Tax Expenses | 273.24M | 247.99M | 255.10M | 266.47M | 256.33M |
| Earnings from Continuing Operations | 96.79 | 505.82 | 558.18 | 642.54 | 659.07 |
| Earnings from Discontinued Operations | -1.17M | -- | 1.08M | -9.30K | -3.24M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -46.71M | -50.90M | -54.56M | -53.94M | -45.49M |
| Net Income | 48.91M | 454.92M | 504.70M | 588.59M | 610.34M |
| EBIT | 579.65M | 896.63M | 942.82M | 1.02B | 1.12B |
| EBITDA | 993.08M | 1.31B | 1.35B | 1.42B | 1.52B |
| EPS Basic | 0.29 | 2.66 | 2.96 | 3.45 | 3.58 |
| Normalized Basic EPS | 1.10 | 2.45 | 2.65 | 3.00 | 3.24 |
| EPS Diluted | 0.27 | 2.64 | 2.94 | 3.44 | 3.57 |
| Normalized Diluted EPS | 1.09 | 2.43 | 2.63 | 2.99 | 3.23 |
| Average Basic Shares Outstanding | 683.60M | 683.40M | 683.10M | 682.90M | 682.70M |
| Average Diluted Shares Outstanding | 689.58M | 690.16M | 689.96M | 688.13M | 683.97M |
| Dividend Per Share | 2.16 | 1.64 | 2.12 | 2.12 | 2.13 |
| Payout Ratio | 814.99% | 81.89% | 71.54% | 61.75% | 60.17% |